Sökning: (WFRF:(Giannakopoulos Panteleimon)) >
Early-Phase 18F-Flo...
Early-Phase 18F-Florbetapir and 18F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting
-
- Boccalini, Cecilia (författare)
- Univ Geneva, Geneva Univ, Neuroctr, Lab Neuroimaging & Innovat Mol Tracers NIMTlab, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland.;Univ Vita Salute San Raffaele, Milan, Italy.;IRCCS, San Raffaele Sci Inst, Div Neurosci, In Vivo Human Mol & Struct Neuroimaging Unit, Milan, Italy.
-
- Peretti, Debora Elisa (författare)
- Univ Geneva, Geneva Univ, Neuroctr, Lab Neuroimaging & Innovat Mol Tracers NIMTlab, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland.
-
- Ribaldi, Federica (författare)
- Univ Geneva, Lab Neuroimaging Aging LANVIE, Geneva, Switzerland.;Geneva Univ Hosp, Memory Clin, Geneva, Switzerland.
-
visa fler...
-
- Scheffler, Max (författare)
- Geneva Univ Hosp, Diagnost Dept, Div Radiol, Geneva, Switzerland.
-
- Stampacchia, Sara (författare)
- Univ Geneva, Geneva Univ, Neuroctr, Lab Neuroimaging & Innovat Mol Tracers NIMTlab, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland.
-
- Tomczyk, Szymon (författare)
- Univ Geneva, Lab Neuroimaging Aging LANVIE, Geneva, Switzerland.
-
- Rodriguez, Cristelle (författare)
- Univ Hosp Geneva, Div Inst Measures, Med Direct, Geneva, Switzerland.;Univ Geneva, Fac Med, Dept Psychiat, Geneva, Switzerland.
-
- Montandon, Marie-Louise (författare)
- Univ Geneva, Fac Med, Dept Psychiat, Geneva, Switzerland.;Geneva Univ Hosp, Dept Rehabil & Geriatr, Geneva, Switzerland.;Univ Geneva, Geneva, Switzerland.
-
- Haller, Sven (författare)
- Uppsala universitet,Radiologi,CIMC Ctr Imagerie Med Cornavin, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland.;Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, Beijing, Peoples R China.
-
- Giannakopoulos, Panteleimon (författare)
- Univ Hosp Geneva, Div Inst Measures, Med Direct, Geneva, Switzerland.;Univ Geneva, Fac Med, Dept Psychiat, Geneva, Switzerland.
-
- Frisoni, Giovanni B. (författare)
- Univ Geneva, Lab Neuroimaging Aging LANVIE, Geneva, Switzerland.;Geneva Univ Hosp, Memory Clin, Geneva, Switzerland.
-
- Perani, Daniela (författare)
- Univ Vita Salute San Raffaele, Milan, Italy.;IRCCS, San Raffaele Sci Inst, Div Neurosci, In Vivo Human Mol & Struct Neuroimaging Unit, Milan, Italy.;Osped San Raffaele, Nucl Med Unit, Milan, Italy.
-
- Garibotto, Valentina (författare)
- Univ Geneva, Geneva Univ, Neuroctr, Lab Neuroimaging & Innovat Mol Tracers NIMTlab, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland.;Geneva Univ Hosp, Div Nucl Med & Mol Imaging, Geneva, Switzerland.;CIBM Ctr Biomed Imaging, Geneva, Switzerland.
-
visa färre...
-
Univ Geneva, Geneva Univ, Neuroctr, Lab Neuroimaging & Innovat Mol Tracers NIMTlab, Geneva, Switzerland;Univ Geneva, Fac Med, Geneva, Switzerland.;Univ Vita Salute San Raffaele, Milan, Italy.;IRCCS, San Raffaele Sci Inst, Div Neurosci, In Vivo Human Mol & Struct Neuroimaging Unit, Milan, Italy. Univ Geneva, Geneva Univ, Neuroctr, Lab Neuroimaging & Innovat Mol Tracers NIMTlab, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland. (creator_code:org_t)
- 2022-07-21
- 2023
- Engelska.
-
Ingår i: Journal of Nuclear Medicine. - : The Society of Nuclear Medicine and Molecular Imaging. - 0161-5505 .- 1535-5667 .- 2159-662X. ; 64:2, s. 266-273
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.2...
-
visa färre...
Abstract
Ämnesord
Stäng
- Alzheimer disease (AD) neuropathologic changes are 6-amyloid (A6) deposition, pathologic tau, and neurodegeneration. Dual-phase amy-loid PET might be able to evaluate A6 deposition and neurodegenera-tion with a single tracer injection. Early-phase amyloid PET scans provide a proxy for cerebral perfusion, which has shown good correla-tions with neural dysfunction measured through metabolic consump-tion, whereas the late frames depict amyloid distribution. Our study aimed to assess the comparability between early-phase amyloid PET scans and 18F-FDG PET brain topography at the individual level and their ability to discriminate patients. Methods: One hundred sixty-six subjects evaluated at the Geneva Memory Center, ranging from no cognitive impairment to mild cognitive impairment and dementia, underwent early-phase amyloid PET-using either 18F-florbetapir (eFBP) (n = 94) or 18F-flutemetamol (eFMM) (n = 72)-and 18F-FDG PET. A6 status was assessed. SUV ratios (SUVRs) were extracted to evaluate the correlation of eFBP/eFMM and their respective 18F-FDG PET scans. The single-subject procedure was applied to investigate hypometabolism and hypoperfusion maps and their spatial overlap by the Dice coefficient. Receiver-operating-characteristic analyses were performed to compare the discriminative power of eFBP/eFMM and 18F-FDG PET SUVR in AD-related meta-regions of interest between A6-negative healthy controls and cases in the AD continuum. Results: Positive correlations were found between eFBP/eFMM and 18F-FDG PET SUVR independently of A6 status and A6 radiotracer (R> 0.72, P< 0.001). eFBP/eFMM single-subject analysis revealed clusters of significant hypoperfusion with good correspondence to hypometabo-lism topographies, independently of the underlying neurodegenerative patterns. Both eFBP/eFMM and 18F-FDG PET SUVR significantly dis-criminated AD patients from controls in the AD-related meta-regions of interest (eFBP area under the curve [AUC], 0.888; eFMM AUC, 0.801), with 18F-FDG PET performing slightly better, although not sig-nificantly (all P values higher than 0.05), than others (18F-FDG AUC, 0.915 and 0.832 for subjects evaluated with eFBP and eFMM, respec-tively). Conclusion: The distribution of perfusion was comparable to that of metabolism at the single-subject level by parametric analysis, particularly in the presence of a high neurodegeneration burden. Our findings indicate that eFBP and eFMM imaging can replace 18F-FDG PET imaging, as they reveal typical neurodegenerative patterns or allow exclusion of the presence of neurodegeneration. The findings show cost-saving capacities of amyloid PET and support routine use of the modality for individual classification in clinical practice.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Nyckelord
- neurodegeneration
- early-phase amyloid PET
- 18F-FDG PET
- individual maps
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Boccalini, Cecil ...
-
Peretti, Debora ...
-
Ribaldi, Federic ...
-
Scheffler, Max
-
Stampacchia, Sar ...
-
Tomczyk, Szymon
-
visa fler...
-
Rodriguez, Crist ...
-
Montandon, Marie ...
-
Haller, Sven
-
Giannakopoulos, ...
-
Frisoni, Giovann ...
-
Perani, Daniela
-
Garibotto, Valen ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Radiologi och bi ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
- Artiklar i publikationen
-
Journal of Nucle ...
- Av lärosätet
-
Uppsala universitet